SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-16-040766
Filing Date
2016-11-02
Accepted
2016-11-01 18:12:35
Documents
60
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q acrx20160817_10q.htm 10-Q 1507275
2 EXHIBIT 4.9 ex4-9.htm EX-4.9 17317
3 EXHIBIT 4.10 ex4-10.htm EX-4.10 16836
4 EXHIBIT 10.1 ex10-1.htm EX-10.1 24197
5 EXHIBIT 10.2 ex10-2.htm EX-10.2 431257
6 EXHIBIT 31.1 ex31-1.htm EX-31.1 10138
7 EXHIBIT 31.2 ex31-2.htm EX-31.2 9799
8 EXHIBIT 32.1 ex32-1.htm EX-32.1 8057
  Complete submission text file 0001437749-16-040766.txt   6049402

Data Files

Seq Description Document Type Size
9 EXHIBIT 101.INS acrx-20160930.xml EX-101.INS 1036457
10 EXHIBIT 101.SCH acrx-20160930.xsd EX-101.SCH 60041
11 EXHIBIT 101.CAL acrx-20160930_cal.xml EX-101.CAL 39642
12 EXHIBIT 101.DEF acrx-20160930_def.xml EX-101.DEF 329998
13 EXHIBIT 101.LAB acrx-20160930_lab.xml EX-101.LAB 315543
14 EXHIBIT 101.PRE acrx-20160930_pre.xml EX-101.PRE 348306
Mailing Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35068 | Film No.: 161965874
SIC: 2834 Pharmaceutical Preparations